Bonk (NASDAQ:BNKK) Raised to Sell at Wall Street Zen

Bonk (NASDAQ:BNKK) was upgraded by equities research analysts at Wall Street Zen to a “sell” rating in a research note issued to investors on Saturday.

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Bonk in a report on Monday, December 8th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Bonk has an average rating of “Sell”.

Bonk Stock Up 26.1%

Shares of Bonk stock opened at $4.06 on Friday. Bonk has a 12 month low of $3.05 and a 12 month high of $46.90. The firm has a market cap of $21.36 million, a price-to-earnings ratio of -18.45 and a beta of 1.82.

Bonk (NASDAQ:BNKK) last released its earnings results on Wednesday, November 19th. The company reported ($3.85) earnings per share for the quarter. The firm had revenue of $1.51 million for the quarter.

About Bonk

Safety Shot, Inc, a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema.